Press Releases by Category Business, Economy, Finances, Banking & Insurance
Top Electronic Shelf Labels Manufacturers: Why ZhSunyco Registered Stands Out
ZhSunyco Registered stands out among electronic shelf labels manufacturers with cutting-edge solutions, seamless POS integration, and global service for retail environments.
Recommendation:
To B or C: B2B
Main Markets: Global
Main Products: Electronic Shelf Labels (ESL), E-Ink Displays, and LCD Displays
Top Electronic Shelf Labels Manufacturers: Why ZhSunyco Registered Stands Out
ZhSunyco Registered has emerged as one of the most trusted electronic shelf labels manufacturers worldwide. Founded in 2016 and backed by over 12 years of…
Colorectal Cancer Market Poised for Steady Growth with a CAGR of 5% through 2034 …
The Colorectal Cancer market size is experiencing substantial growth across the 7MM, driven by an aging population, introduction of innovative therapies, such as KRAS and HER2 inhibitors, improved screening methods, and changes in dietary habits. Key companies, including Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Genentech, MSD, Takeda, Seagen, Amgen, Pfizer, Roche, Genentech, GenFleet Therapeutics, InventisBio, BioNTec, and AbbVie, among others are driving innovations.
According to the latest insights from DelveInsight's comprehensive report,…
Nonmelanoma Skin Cancer Market Poised for Significant Growth by 2034, Driven by …
The Nonmelanoma Skin Cancer market is expected to experience substantial growth from 2024 to 2034, driven by increasing disease prevalence, advancements in diagnostic techniques, and the introduction of novel treatment options by leading Nonmelanoma Skin Cancer companies actively advancing research in this landscape including Sensus Healthcare, DUSA Pharmaceuticals Inc., Skin Analytics Limited, Pfizer, Bristol-Myers Squibb, Sirnaomics, AiViva BioPharma, and Exicure, among others.
DelveInsight's "Nonmelanoma Skin Cancer Market Insight, Epidemiology, and Market…
Astrocytoma Market to See Strong Growth Through 2034 as Pfizer, Merck, Novartis, …
The Astrocytoma market is anticipated to experience significant growth through 2034. The increasing incidence of brain tumors, diagnostic techniques and growing R&D activity, is expected to drive this market growth during the forecast period. Key companies such as Pfizer, Merck, Novartis, Roche, Amgen, Teva Pharmaceutical, Boehringer Ingelheim, Eisai, Denovo Biopharma, Orbus Therapeutics, and Breckenridge, among others, are driving innovation in the Astrocytoma treatment landscape.
DelveInsight's latest "Astrocytoma Market Insight, Epidemiology and…
Metastatic Bone Pain Market Poised for Expansion with Advances in Targeted Thera …
DelveInsight's latest market research report highlights significant growth opportunities in the metastatic bone pain market across 7MM, providing comprehensive insights on emerging therapies, epidemiological trends, and market forecasts for the coming decade. Metastatic bone pain key players include Novartis, Amgen, Bayer, Radius Health, Eli Lilly, Merck, Pfizer, BMS, GlaxoSmithKline, AstraZeneca, Roche Holding, Sanofi, Ipsen Pharma, and Servier Laboratories, among others.
According to DelveInsight's "Metastatic Bone Pain Market Insights, Epidemiology, and Market…
Wearable Medical Devices Market to Soar at 13.67% CAGR Through 2032, Driven by A …
DelveInsight forecasts the wearable medical devices market to grow at a 13.67% CAGR through 2032, fueled by aging populations, rising chronic diseases, and tech advancements. Key players include Philips, Omron, Medtronic, Dexcom, Fitbit, Garmin, Apple, and Masimo, offering solutions for monitoring, diagnostics, and fitness. AI integration, FDA approvals, and expanding applications drive global adoption.
DelveInsight's "Wearable Medical Devices -Market Insights, Competitive Landscape and Market Forecast - 2032 [https://www.delveinsight.com/report-store/wearable-medical-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers a…
Active Implantable Medical Devices Market is Expected to Grow Significantly from …
DelveInsight's comprehensive analysis highlights significant Active Implantable Medical Devices Market expansion driven by rising chronic disease prevalence, technological innovations by manufacturers including Medtronic plc., Abbott, Boston Scientific Corporation, Johnson and Johnson Services Inc., LivaNova PLC., CARMAT, Cochlear Ltd., NEVRO CORP., and others, and increasing healthcare awareness across global markets.
DelveInsight's "Active Implantable Medical Devices Market Insights, Competitive Landscape, and Market Forecast - 2032 [https://www.delveinsight.com/report-store/active-implantable-medical-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers a comprehensive analysis of the…
FGFR Inhibitor Market Set for Robust Growth Through 2034 with New FDA clearances …
DelveInsight projects significant FGFR inhibitor market growth through 2034, driven by rising diagnoses, broader indications, and next-gen therapies. Key players include Johnson & Johnson, AstraZeneca, Tyra Biosciences, Abbisko Therapeutics, Taiho Oncology, and Incyte, with leading drugs like BALVERSA, LYTGOBI, PEMAZYRE, TYRA-300, ABSK061, and TAR-210 targeting cancers and autoimmune diseases.
DelveInsight's "FGFR inhibitors - Market Size, Target Population, Competitive Landscape, and Market Forecast - 2034 [https://www.delveinsight.com/report-store/fgfr-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers a comprehensive analysis of…
FcRn Inhibitor Market Outlook 2034: FDA Approvals, Emerging Therapies, Expanding …
DelveInsight forecasts strong growth in the FcRn inhibitor market through 2034, driven by rising autoimmune diagnoses and expanding indications. Key players include Johnson & Johnson, UCB Biopharma, Pfizer, Immunovant, ArgenX, and Viridian Therapeutics, with leading drugs like VYVGART, RYSTIGGO, batoclimab, and nipocalimab. Regulatory milestones, robust pipelines, and commercial success position FcRn inhibitors for sustained market expansion.
DelveInsight's "FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 [https://www.delveinsight.com/report-store/fcrn-inhibitor-competitive-landscape-and-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]"…
Arteriovenous Fistula Pipeline Insight 2025: Endovascular Innovations and Bioeng …
The therapeutic pipeline for AV fistula creation and maintenance is rapidly evolving, driven by rising ESRD cases and limitations of current surgical methods. Despite being the preferred access for hemodialysis, AV fistulas face issues like maturation failure and thrombosis. To address these challenges, research is focusing on device innovations, biologically active materials, and minimally invasive techniques to enhance success and long-term function.
DelveInsight's "Arteriovenous (AV) Fistula - Pipeline Insight, 2025 [https://www.delveinsight.com/report-store/arteriovenous-fistula-av-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]"…
Chronic Rhinosinusitis Pipeline Insight 2025: Targeted Biologics and Innovative …
The therapeutic pipeline for chronic rhinosinusitis (CRS) is shifting toward targeted biologics, oral small molecules, and advanced delivery systems to address its complex inflammation. Standard treatments offer only temporary relief, with frequent recurrence-especially in CRSwNP patients-driving demand for therapies that provide lasting control and reduce reliance on surgery and steroids.
DelveInsight's "Chronic Rhinosinusitis - Pipeline Insight, 2025 [https://www.delveinsight.com/report-store/chronic-rhinosinusitis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" reveals a strong pipeline targeting both type 2 inflammation (via IL-4/IL-13, IL-5, and…
Chronic Periodontitis Pipeline Insight 2025: Regenerative Therapies and Host-Mod …
The therapeutic pipeline for chronic periodontitis is advancing, with growing interest in regenerative medicine, host-modulation, and novel antimicrobials. Current treatments can slow progression but rarely reverse tissue loss or fully eliminate biofilms, highlighting the need for therapies that both control disease and restore periodontal structures.
DelveInsight's "Chronic Periodontitis - Pipeline Insight, 2025 [https://www.delveinsight.com/report-store/chronic-periodontitis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" highlights a diverse portfolio of candidates aimed at modulating the host immune response, regenerating bone and connective tissue,…
Angioimmunoblastic T-Cell Lymphoma Pipeline Insight 2025: Targeted Immunotherapi …
The therapeutic pipeline for angioimmunoblastic T-cell lymphoma (AITL) is growing, driven by the need to address its aggressive nature and poor prognosis. Current treatments, such as CHOP-like chemotherapy and stem cell transplants, often result in high relapse rates and limited long-term responses. In response, R&D is increasingly focused on targeting key molecular drivers like T-cell receptor signaling, epigenetic changes, and the tumor microenvironment.
DelveInsight's "Angioimmunoblastic T-Cell Lymphoma - Pipeline Insight, 2025…
Erosive Esophagitis Pipeline Insight 2025: Advancing Beyond Acid Suppression Tow …
The treatment of erosive esophagitis (EE), a severe form of GERD causing esophageal damage, is evolving beyond proton pump inhibitors (PPIs). Despite PPIs being the standard therapy, issues like incomplete healing, symptom recurrence, and PPI resistance highlight the need for new treatments that better address the disease, sustain remission, and improve patient adherence, driving increased R&D efforts.
DelveInsight's "Erosive Esophagitis - Pipeline Insight, 2025 [https://www.delveinsight.com/report-store/erosive-esophagitis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" underscores the momentum in drug development…
Acute Lymphocytic Leukemia Clinical Trials, Companies, Therapeutic Assessment, T …
DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight, 2025," report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in Acute Lymphocytic Leukemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, the Acute Lymphocytic Leukemia pipeline includes…
Dilated Cardiomyopathy Clinical Trials, Companies, Therapeutic Assessment, Emerg …
"DelveInsight's, "Dilated Cardiomyopathy - Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Dilated Cardiomyopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that the Dilated Cardiomyopathy pipeline includes over eight…
Chronic Spontaneous Urticaria Clinical Trials, Companies, Therapeutic Assessment …
DelveInsight's, "Chronic Spontaneous Urticaria- Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Chronic Spontaneous Urticaria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over 20 key companies are actively…
Postpartum Depression Clinical Trials, Companies, Therapeutic Assessment, Therap …
DelveInsight's, "Postpartum Depression - Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum Depression pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, the Postpartum Depression pipeline features over 10…
Retinal Vein Occlusion Clinical Trials, Companies, Therapeutic Assessment, Thera …
DelveInsight's, "Retinal Vein Occlusion - Pipeline Insight, 2025," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Retinal Vein Occlusion pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over 15 key companies are…
Multiple System Atrophy Clinical Trials, Companies, Therapeutic Assessment, Ther …
DelveInsight's, "Multiple System Atrophy- Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Multiple System Atrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over 20 key companies are actively…
AAV Vectors in Gene Therapy Clinical Trials, Companies, Therapeutic Assessment, …
DelveInsight's, "Adeno-Associated Virus (AAV) Vectors in Gene Therapy - Pipeline Insight, 2025" report provides comprehensive insights about 180+ companies and 250+ pipeline drugs in AAV Vectors in Gene Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports…
Alzheimer's disease Clinical Trials, Companies, Therapeutic Assessment, Therapie …
DelveInsight's, "Alzheimer's disease Pipeline Insight, 2025" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer's disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over 110 key companies are actively engaged in…
Tendonitis Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessm …
DelveInsight's, "Tendonitis Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Tendonitis pipeline landscape. It covers the Tendonitis pipeline drug profiles, including Tendonitis clinical trials and nonclinical stage products. It also covers the Tendonitis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that more than four key companies…
Acoustic Neuroma Market Outlook 2034 - Clinical Trials, Market Size, Medication, …
Acoustic Neuroma companies are Akouos, Amgen, Roche, Natus Medical Incorporated, Elekta, Pfizer Inc., Roche AG, CIVCO MEDICAL SOLUTIONS, Novartis AG, MAICO Diagnostics GmbH, Siemens Healthcare GmbH, Interacoustics A/S, Natus Medical Incorporated, and others.
(Albany, USA) DelveInsight's report, "Acoustic Neuroma Market Insights, Epidemiology, and Market Forecast-2034", offers a comprehensive analysis of Acoustic Neuroma, including historical and projected epidemiology, along with market trends across the United States, the EU5 (Germany, Spain, Italy, France,…
Adenoid cystic carcinoma Market Outlook 2034 - Clinical Trials, Market Size, Med …
Adenoid cystic carcinoma companies are OncoC4, Ascentage Pharma, Elevar Therapeutics, CELLESTIA BIOTECH AG, Remix Therapeutics, Rgenta Therapeutics Inc and others.
(Albany, USA) DelveInsight's "Adenoid cystic carcinoma Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Adenoid cystic carcinoma, historical and forecasted epidemiology as well as the Adenoid cystic carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Adenoid cystic carcinoma…
Soft tissue sarcoma Market Outlook 2034 - Clinical Trials, Market Size, Medicati …
Leading Soft tissue sarcoma companies working in the market are Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Apexigen, Lytix Biopharma, Incyte Corporation, Iovance Biotherapeutics, Aadi Bioscience, Inc., AVEO Pharmaceuticals, Bayer, VasGene Therapeutics, Mirati Therapeutics, Novartis Pharmaceuticals, Incyte Corporation, Tracon Pharmaceuticals, Exelixis, Qbiotics, AstraZeneca, Loxo Oncology, more
(Albany, USA) DelveInsight's "Soft tissue sarcoma Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of…
Acute Agitation and Aggression Market Outlook 2034 - Clinical Trials, Market Siz …
Acute Agitation and Aggression companies are BioXcel Therapeutics, Otsuka Pharmaceutical/Lundbeck, Axsome Therapeutics, Suven Life Sciences, Intra-Cellular Therapies/Johnson & Johnson, Others.
(Albany, USA) DelveInsight's report, "Acute Agitation and Aggression Market Insights, Epidemiology, and Market Forecast-2034", offers a comprehensive analysis of Acute Agitation and Aggression, including historical and projected epidemiology, along with market trends across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
The report examines current treatment…
ESCLC Pipeline Assessment Report 2025: Key 25+ Companies and Breakthrough Therap …
DelveInsight's, "Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline Insight, 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Extensive-Stage Small Cell Lung Cancer (ESCLC) pipeline landscape. It covers the ESCLC pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ESCLC pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Microbiome Disease Pipeline Outlook Report 2025: Key 140+ Companies and Breakthr …
DelveInsight's, "Microbiome Disease Pipeline Insights 2025" report provides comprehensive insights about 140+ companies and 180+ pipeline drugs in Microbiome Disease pipeline landscape. It covers the Microbiome Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Microbiome Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive report now to…
Atopic Dermatitis Pipeline Outlook Report 2025: Key 100+ Companies and Breakthro …
DelveInsight's, "Atopic Dermatitis Pipeline Insight, 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Atopic Dermatitis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive report now to…
Chronic Kidney Disease Pipeline Outlook Report 2025: Key 75+ Companies and Break …
DelveInsight's, "Chronic Kidney Disease Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Kidney Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Cutaneous T-Cell Lymphoma Pipeline Drugs Report 2025: Key 25+ Companies and Brea …
DelveInsight's "Cutaneous T-cell lymphoma Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Cutaneous T-cell lymphoma pipeline landscape. It covers the Cutaneous T-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cutaneous T-Cell Lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Non-Small Cell Lung Cancer Pipeline Outlook Report 2025: Key 100+ Companies and …
DelveInsight's, Non-Small-Cell Lung Cancer (NSCLC) Pipeline Insights 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the Non-Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive…
Acute Lymphocytic Leukemia Pipeline Outlook Report 2025: Key 125+ Companies and …
DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight 2025" report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in Acute Lymphocytic Leukemia pipeline landscape. It covers the Acute Lymphocytic Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Acute Lymphocytic Leukemia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…
New business class to Latin America; an elevated way to fly on over 80 selected …
Image: https://www.globalnewslines.com/uploads/2025/08/1754920523.jpg
A's new Business Class to Latin America transforms regional travel across over 80 selected routes throughout the Americas. It delivers an enhanced experience that reflects the airline's commitment to elevated service and authentic Latin American hospitality, aiming to elevate the entire journey.
A seamless journey
The journey begins even before boarding, offering travelers a moment of calm to relax and prepare for their flight. Priority boarding ensures a smooth and stress-free…
Multiple Myeloma Pipeline Outlook Report 2025: Key 75+ Companies and Breakthroug …
DelveInsight's "Multiple Myeloma Pipeline Insights 2025" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It covers the Multiple Myeloma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Myeloma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights…
Sunshine Locksmiths; Trusted Locksmith, Shutter & Door Experts on the Costa del …
Image: https://www.globalnewslines.com/uploads/2025/08/1754920180.jpg
When it comes to the safety and security of your home or business, there's no room for compromise. Whether you're locked out, upgrading your property, or simply maintaining your peace of mind, Sunshine Locksmiths is the name you can trust across the Costa del Sol.
Based in Estepona and serving the areas of Marbella, San Pedro, Manilva, Casares, Cancelada, and Sotogrande, we offer fast, friendly, and reliable locksmith and security…
RIPK1 Inhibitor Pipeline Outlook Report 2025: Key 10+ Companies and Breakthrough …
DelveInsight's, "RIPK1 inhibitor Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in RIPK1 inhibitor pipeline landscape. It covers the RIPK1 Inhibitor pipeline RIPK1 inhibitor drug profiles, including RIPK1 inhibitor clinical and nonclinical stage products. It also covers the RIPK1 inhibitor therapeutics assessment by product type, stage, RIPK1 inhibitor route of administration, and RIPK1 inhibitor molecule type. It further highlights the inactive pipeline products in…
HR Positive/ HER2 Negative Breast Cancer Pipeline Outlook Report 2025: Key 50+ C …
DelveInsight's, "HR Positive/ HER2 Negative Breast Cancer Pipeline Insight, 2025," report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2 Negative Breast Cancer pipeline landscape. It covers the HR Positive/ HER2 Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HR Positive/ HER2 Negative Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule…
Vascular Dementia Pipeline Outlook Report 2025: Key 11+ Companies and Breakthrou …
DelveInsight's, "Vascular Dementia Pipeline Insight, 2025," report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Vascular Dementia pipeline landscape. It covers the Vascular Dementia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Vascular Dementia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive report now to…
Cough in Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2025: Key 5+ Comp …
DelveInsight's, "Cough in Idiopathic Pulmonary Fibrosis (IPF) Pipeline Insight, 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cough in Idiopathic Pulmonary Fibrosis (IPF) pipeline landscape. It covers the Cough in Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cough in Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It…
Epidermolysis Bullosa Pipeline Outlook Report 2025: Key 20+ Companies and Breakt …
DelveInsight's, "Epidermolysis Bullosa Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the Epidermolysis Bullosa pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epidermolysis Bullosa pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive report now to…
Global Milk Powder Easy Open Lid Market to Double by 2033, Driven by Demand for …
The global Milk Powder Easy Open Lid market will grow from USD 1.2 billion in 2024 to USD 2.5 billion by 2033 at an 8.5% CAGR. Growth is fueled by rising demand for convenient, safe, and sustainable packaging in dairy products. Key drivers include urbanization, e-commerce expansion, and eco-friendly innovations, with China and India leading growth. Major players focus on R&D, recyclable materials, and customizable premium designs.
[London, UK - August…
$3 Billion Suicidal Depression Market May Soon be Accessible via FDA Fast Track …
Image: https://www.globalnewslines.com/uploads/2025/08/1754917343.jpg
$NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
* Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal Treatment-Resistant Bipolar Depression and Chronic Pain.
* Designed to Help Address the Needs of Over 13 Million Americans who Seriously Consider Suicide Each Year (CDC).
* FDA Fast Track Designation for NRX…
Dickie Shearer Launches New Instagram to Champion the Global South
The new account will focus on building a community dedicated to shared learning, deeper understanding, and practical support for individuals, businesses, and cultures across emerging markets.
Image: https://www.globalnewslines.com/uploads/2025/08/87f1a105b7ec35f1f58c43132f4dc8a6.jpg
Dickie Shearer is pleased to announce the official launch of his new Instagram account, @dickie_shearer [https://www.instagram.com/dickie_shearer], created as a digital space to connect, discuss, and elevate voices across the Global South. The page will serve as a home for ideas at the intersection of…
Zutec Secures Strategic Recapitalisation by Pictet Asset Management
Image: https://www.globalnewslines.com/uploads/2025/08/51accffd91c1261494ff217984575602.jpg
Gustave Geisendorf, CEO, Zutec Zutec [https://zutec.com/], a leading provider of ConTech and PropTech SaaS solutions in the UK and Ireland, is pleased to announce the successful completion of a strategic recapitalisation by Pictet Asset Management [https://am.pictet.com/uk/en]'s ("Pictet AM") European Direct Lending arm.
Zutec's strategy is built on profitable organic growth as well as acquiring and partnering with complementary businesses to accelerate growth. The recapitalisation by Pictet AM includes new facilities…
open your mind to Exploration, smart and Trek Unveil Collaborative e-MTB Inspire …
*
smart and Trek have premiered their latest collaborative creation, the smart x Trek Rail+ 9.9 Gen 5 e-MTB at Milan Design Week, alongside the world premiere of the smart #5 BRABUS which inspired its design.
*
The partnership brings to life smart's "open your mind" brand claim through collaborations with outdoor pioneers, matching the smart #5's label as a "Contemporary Adventurer".
*
The Rail+ 9.9 Gen 5 e-MTB combines performance features with…
Junk Quest Marks 600 Five-Star Review Milestone Highlights Service to McKinney N …
McKinney's own Junk Quest - a family-owned junk removal service - is celebrating a milestone of over 600 five-star Google reviews, reflecting widespread community trust. From Historic Downtown to Stonebridge Ranch, Junk Quest has become the go-to junk hauling team across local neighborhoods, known for fast service, charitable donations, and a neighborly approach to business.
Junk Quest - McKinney Junk Removal is celebrating a major vote of confidence from its hometown…
Jumbotron Screens Announces Strategic Collaboration with OOHA to Transform Urban …
Wilmington, DE, USA - August 11, 2025 - In the dynamic world of Out-of-Home Advertising (OOHA) in the United States, visibility and impact are paramount. Amidst a sea of static billboards and traditional signage, Jumbotron Screens are emerging as the ultimate solution for brands looking to capture attention and leave a lasting impression on urban audiences. Leveraging cutting-edge LED screen technology, Jumbotron Screens are transforming building facades into vibrant, dynamic…
EventRent Delivers Premium Tailgate Experience as Official Partner of Boise Stat …
Image: https://www.globalnewslines.com/uploads/2025/08/1754486049.jpg
EventRent Idaho is proud to be the Official Partner of Boise State Athletics, delivering a turnkey tailgating experience in the Ford Tailgate Zone at DeChevrieux Field, just outside Albertsons Stadium. Tailgate packages include tents, lounge seating, coolers, TVs, and full setup and teardown by EventRent's team-ideal for 10 to 100+ guests. Fans also enjoy food trucks, a Kids Zone, and the option to bring their own food and beverages.…
Go To Page 21401 21400 21399 21398 21397 21396 21395 21394 21393 21392 18111 18110 18109 18108 18107 18106 18105 18104 18103 18102
